ICU blood clot study: tracking thinner levels to save lives
NCT ID NCT06357403
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study observes 1,300 critically ill ICU patients to see if the level of a blood thinner (enoxaparin) in their blood is linked to dangerous blood clots. Researchers will track clots, bleeding, and patient outcomes like survival and hospital stay length. The goal is to find better ways to prevent clots in intensive care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna
RECRUITINGVienna, 1090, Austria
Contact
-
Department of Internal Medicine, Medical University of Graz
RECRUITINGGraz, Styria, 8063, Austria
Contact
Conditions
Explore the condition pages connected to this study.